Tomoya Uehara

1.9k total citations
87 papers, 1.5k citations indexed

About

Tomoya Uehara is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tomoya Uehara has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Radiology, Nuclear Medicine and Imaging, 41 papers in Pulmonary and Respiratory Medicine and 26 papers in Oncology. Recurrent topics in Tomoya Uehara's work include Radiopharmaceutical Chemistry and Applications (64 papers), Medical Imaging and Pathology Studies (31 papers) and Medical Imaging Techniques and Applications (20 papers). Tomoya Uehara is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (64 papers), Medical Imaging and Pathology Studies (31 papers) and Medical Imaging Techniques and Applications (20 papers). Tomoya Uehara collaborates with scholars based in Japan, United States and Thailand. Tomoya Uehara's co-authors include Yasushi Arano, Hiromichi Akizawa, Hideo Saji, Hiroyuki Suzuki, Kazuma Ogawa, Hirofumi Hanaoka, Takahiro Mukai, Yasushi Fujioka, Masahiro Ono and Morio Nakayama and has published in prestigious journals such as Circulation, Analytical Chemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Tomoya Uehara

83 papers receiving 1.5k citations

Peers

Tomoya Uehara

RNMI

ONCOL

PRM

EPIDE

Alan Cuthbertson Norway

Lihui Wei United States

John Lister‐James United States

Eleni Gourni Germany

Richard Looby United States

Young‐Seung Kim United States

Hiromichi Akizawa Japan

Thijs H. Oude Munnink Netherlands

Thorsten Poethko Germany

Weijun Wei China

Alan Cuthbertson Norway

Tomoya Uehara

925 ×0.9

RNMI

377 ×0.7

ONCOL

368 ×0.9

PRM

380 ×1.3

90 ×0.5

EPIDE

Citations per year, relative to Tomoya Uehara Tomoya Uehara (= 1×) peers Alan Cuthbertson

Countries citing papers authored by Tomoya Uehara

Since Specialization

Citations

This map shows the geographic impact of Tomoya Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Uehara more than expected).

Fields of papers citing papers by Tomoya Uehara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Uehara. The network helps show where Tomoya Uehara may publish in the future.

Co-authorship network of co-authors of Tomoya Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Uehara. A scholar is included among the top collaborators of Tomoya Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Uehara. Tomoya Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suzuki, Hiroyuki, Shoko Tanaka, Yasuhiro Ohshima, et al.. (2025). An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2107–2117. 3 indexed citations

Jin, Zhao-Hui, Mélissa Degardin, Takako Furukawa, et al.. (2025). Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [⁶⁴Cu]Cu-Labeled Multimeric cRGD Peptide. ACS Omega. 10(4). 4102–4120.

Suzuki, Hiroyuki, Tadashi Watabe, Kazuhiro Ooe, et al.. (2024). Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics. EJNMMI Radiopharmacy and Chemistry. 9(1). 17–17. 9 indexed citations

Takahashi, Kazuhiro, Seiji Hoshi, Koki Hasegawa, et al.. (2024). Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 469–481. 5 indexed citations

Suzuki, Hiroyuki, et al.. (2024). Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies. Pharmaceuticals. 17(4). 508–508. 4 indexed citations

Muchtaridi, Muchtaridi, et al.. (2024). Investigation of a Radio-Iodinated Alpha-Mangostin for Targeting Estrogen Receptor Alpha (ERα) in Breast Cancer: In Silico Design, Synthesis, and Biological Evaluation. Drug Design Development and Therapy. Volume 18. 4511–4526. 2 indexed citations

Uehara, Tomoya. (2024). Chemical Design of Radiohalogenated Agents Using Neopentyl Structure. YAKUGAKU ZASSHI. 144(3). 285–290. 1 indexed citations

Suzuki, Hiroyuki, et al.. (2024). In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure. EJNMMI Radiopharmacy and Chemistry. 9(1). 48–48. 8 indexed citations

Nakamoto, Yuji, Shingo Baba, Hayato Kaida, Osamu Manabe, & Tomoya Uehara. (2023). Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects. Annals of Nuclear Medicine. 38(1). 10–19. 8 indexed citations

10.

Zhang, Yiting, et al.. (2022). Stannous colloid mixed with indocyanine green as a tracer for sentinel lymph node navigation surgery. Scientific Reports. 12(1). 17056–17056. 1 indexed citations

11.

Matsuda, Hiroshi, Tomoya Uehara, Hidehiko Okazawa, et al.. (2020). Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan. Annals of Nuclear Medicine. 34(4). 299–304. 6 indexed citations

12.

Uehara, Tomoya, et al.. (2019). The synthesis of a ^99mTc-labeled tetravalent targeting probe upon isonitrile coordination to ^99mTc^I for enhanced target uptake in saturable systems. RSC Advances. 9(45). 26126–26135. 6 indexed citations

13.

Uehara, Tomoya, et al.. (2018). A Gallium-67/68–Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake. Clinical Cancer Research. 24(14). 3309–3316. 44 indexed citations

14.

Hanaoka, Hirofumi, Yasuhiro Ohshima, Aiko Yamaguchi, et al.. (2015). Development of a Widely Usable Amino Acid Tracer: ⁷⁶Br-α-Methyl-Phenylalanine for Tumor PET Imaging. Journal of Nuclear Medicine. 56(5). 791–797. 20 indexed citations

15.

Yoshida, Chisato, Atsushi B. Tsuji, Hitomi Sudo, et al.. (2010). Development of positron emission tomography probe of 64Cu-labeled anti-C-kit 12A8 Fab to measure protooncogene C-kit expression. Nuclear Medicine and Biology. 38(3). 331–337. 19 indexed citations

16.

Akizawa, Hiromichi, Tomoya Uehara, & Yasushi Arano. (2008). Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins. Advanced Drug Delivery Reviews. 60(12). 1319–1328. 93 indexed citations

17.

Uehara, Tomoya, et al.. (2003). In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives. Nuclear Medicine and Biology. 30(3). 327–334. 18 indexed citations

18.

Akizawa, Hiromichi, Yasushi Arano, Masaki Mifune, et al.. (2001). Effect of molecular charges on renal uptake of 111 In-DTPA-conjugated peptides. Nuclear Medicine and Biology. 28(7). 761–768. 84 indexed citations

19.

Ono, Masahiro, Yasushi Arano, Takahiro Mukai, et al.. (2001). Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides. Nuclear Medicine and Biology. 28(2). 155–164. 37 indexed citations

20.

Ono, Masahiro, Yasushi Arano, Takahiro Mukai, et al.. (2001). 99mTc-HYNIC-derivatized ternary ligand complexes for 99mTc-labeled polypeptides with low in vivo protein binding. Nuclear Medicine and Biology. 28(3). 215–224. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact